Featured News

GHTC director Jamie Bay Nishi delivered in-person testimony on March 12 before the House Appropriations Subcommittee on State, Foreign Operations, and Related Programs on the fiscal year 2021 budget for Global Health Programs at the US Agency for International Development and State Department.

Learn More

PATH/Matthew Dakin
GHTC joins civil society in urging G20 leaders to strengthen R&D to meet critical health challenges

GHTC joined civil society in urging G20 policymakers at today’s C20 meeting with the G20 Health Working Group to strengthen R&D to meet urgent health challenges, including achieving universal health coverage and combating antimicrobial resistance and other health threats. 

Learn More

PATH/ Patrick McKern
GHTC joins InterAction in calling on G7 to prioritize health

GHTC joined the humanitarian and development coalition InterAction in calling on G7 foreign ministers to prioritize health on the 2020 G7 agenda. The coalition released a policy report, including a section on health co-authored by GHTC, which urges the G7 to investment in R&D for new health tools.

PDF

PATH/Doune Porter
GHTC submits FY21 testimony to House appropriators

GHTC submitted written testimony to key House appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.

Learn More

PATH/Patrick McKern
GHTC sends FY21 letters to Congressional appropriators

GHTC sent letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.

Learn More

US government
GHTC director Jamie Bay Nishi delivers testimony on Capitol Hill
GHTC director Jamie Bay Nishi delivered in-person testimony on March 12 before the House Appropriations Subcommittee on State, Foreign Operations, and Related Programs on the fiscal year 2021 budget for Global Health Programs at the US Agency for International Development and State Department.
Learn More
View All News

US government
GHTC condemns President’s proposed cuts to global health and medical research

GHTC condemns President Trump’s fiscal year 2021 budget request seeking deep cuts to global health and medical research programs. The budget proposes a 34 percent cut to global health programs at the US Agency for International Development and the State Department, as well as significant cuts to public health and research agencies within the Department of Health and Human Services. 

Learn More

PATH/Georgina Goodwin
Federal Spending Package Includes Bill to Boost Fight Against Neglected Tropical Diseases

Statement from Jamie Bay Nishi, Director of the Global Health Technologies Coalition, on the passage of the End Neglected Tropical Diseases Act, which was included in H.R. 1865, the Further Consolidated Appropriations Act, 2020, passed by Congress on December 19, 2019.

Learn More

Representatives Anna Eshoo and Mario Diaz-Balart and developers of the RTS,S malaria vaccine honored with GHTC Innovating for Impact Awards
GHTC yesterday honored Congresswoman Anna Eshoo (D-CA) and Congressman Mario Diaz-Balart (R-FL) for their leadership in supporting global health research and development (R&D) at its 2019 Innovating for Impact Awards, an initiative celebrating the US policymakers and partnerships driving global health innovation. GHTC also recognized the partnership that developed the RTS,S malaria vaccine—the world’s first malaria vaccine—for its efforts to advance this breakthrough technology.
Learn More

CDC/James Gathany
GHTC Statement on the Okayama Declaration of the G20 Health Ministers Meeting

The Global Health Technologies Coalition is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development initiatives to combat antimicrobial resistance and improve public health preparedness.

Learn More

PATH
US FDA Approves New TB Drug in Treatment to Cure Practically Incurable XDR-TB

Statement from Jamie Bay Nishi, Director, Global Health Technologies Coalition, on the US Food and Drug Administration’s approval of pretomanid, a new drug developed by the nonprofit TB Alliance.

Learn More
View All Announcements
PATH/Patrick McKern
Research Roundup: Coronavirus not mutating quickly, FDA authorizes plasma treatment for COVID-19, and new COVID-19 rapid diagnostic
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Read More
PATH/Gabe Bienczycki
Research Roundup: Access to experimental COVID-19 drug paused, WHO to launch coronavirus drug trial, and Takeda's dengue vaccine shows promise in clinical trials
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Read More
PATH/Patrick McKern
Research Roundup: Coronavirus vaccine trial starts, second patient cured of HIV, and new collaboration fills data gap on use of antimalarials in pregnancy
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Read More
PATH/Doune Porter
Research Roundup: New TB drug regimen for drug-resistant infections, Gates Foundation to fund study for coronavirus cure, and long-acting treatment for HIV
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Read More
PATH/Matthew Dakin
Research Roundup: WHO launches digital EML, coronavirus vaccine ready for testing, and coronavirus treatment study underway
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Read More
View Breakthroughs Blog

PATH/Eric Becker
Infectious Disease News quotes GHTC on President's proposed budget cuts

GHTC's US Policy Officer Emily Conron spoke with Healio Infectious Disease News about the disastrous impact the President's proposed budget cuts could have on global health R&D.

View

PATH/Rocky Prajapati
Devex features op-ed from GHTC director on role of innovation in achieving healthy lives for all

Devex featured an op-ed from GHTC's Director Jamie Bay Nishi making a case that to achieve healthy lives for all, we need a "one-two punch" of innovation and access.

View

PATH/Eric Becker
GHTC Director quoted in Healio Infectious Disease News on the passage of the End NTDs Act
Healio Infectious Disease News quoted GHTC Director Jamie Bay Nishi in an article on the fiscal year 2020 spending packages, which includes the End NTDs Act.
View

GHTC
Homeland Preparedness News covers GHTC awards

Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).

View

PATH/Matthew Dakin
GHTC op-ed featured in The Hill

A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill

View
View All GHTC in the Media

PATH/Matthew Dakin
GHTC joins civil society in urging G20 leaders to strengthen R&D to meet critical health challenges

GHTC joined civil society in urging G20 policymakers at today’s C20 meeting with the G20 Health Working Group to strengthen R&D to meet urgent health challenges, including achieving universal health coverage and combating antimicrobial resistance and other health threats. 

Learn More

PATH/ Patrick McKern
GHTC joins InterAction in calling on G7 to prioritize health

GHTC joined the humanitarian and development coalition InterAction in calling on G7 foreign ministers to prioritize health on the 2020 G7 agenda. The coalition released a policy report, including a section on health co-authored by GHTC, which urges the G7 to investment in R&D for new health tools.

PDF

PATH/Doune Porter
GHTC submits FY21 testimony to House appropriators

GHTC submitted written testimony to key House appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.

Learn More

PATH/Patrick McKern
GHTC sends FY21 letters to Congressional appropriators

GHTC sent letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.

Learn More

US government
GHTC director Jamie Bay Nishi delivers testimony on Capitol Hill
GHTC director Jamie Bay Nishi delivered in-person testimony on March 12 before the House Appropriations Subcommittee on State, Foreign Operations, and Related Programs on the fiscal year 2021 budget for Global Health Programs at the US Agency for International Development and State Department.
Learn More
View All Advocacy Actions

Events

Community Event

PATH/Patrick McKern
17th Annual Global Health & Innovation Conference
Unite for Sight
Learn More

Community Event

11th Annual CUGH Conference
Consortium of Universities for Global Health
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org